LEADER 03616nam  2200589 a 450 
001 9910830050703321
005 20230617025016.0
010   $a1-280-28482-X
010   $a9786610284825
010   $a0-470-70943-X
010   $a0-470-98683-2
010   $a0-470-98684-0
010   $a1-4051-2336-2
035   $a(CKB)111087027742280
035   $a(EBL)214167
035   $a(OCoLC)475920133
035   $a(SSID)ssj0000104344
035   $a(PQKBManifestationID)11122179
035   $a(PQKBTitleCode)TC0000104344
035   $a(PQKBWorkID)10084900
035   $a(PQKB)11782560
035   $a(MiAaPQ)EBC214167
035   $a(EXLCZ)99111087027742280
100   $a20020620d2003      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAnxiety disorders$b[electronic resource] /$fedited by D.J. Nutt, J.C. Ballenger
210   $aMalden, Mass. $cBlackwell Science$d2003
215   $a1 online resource (556 p.)
300   $aDescription based upon print version of record.
311   $a0-632-05938-9 
320   $aIncludes bibliographical references and index.
327   $aAnxiety Disorders; Contents; Contributors; Preface; PART ONE: Introduction; 1. Conceptual Antecedents of the Anxiety Disorders; PART TWO: Symptoms and Syndromes; 2. Relationships Among Anxiety Disorders: Patterns and Implications; 3. Panic Disorder: Symptoms and Syndromes; 4. Generalized Anxiety Disorder; 5. Post-traumatic Stress Disorder; 6. Obsessive-compulsive Disorder; 7. Social Anxiety Disorder; 8. Sleep Aspects of Anxiety Disorders; 9. Childhood Antecedents of Adult Anxiety Disorders; 10. Anxiety and Schizophrenia; PART THREE: Mechanisms; 11. Neurochemical Aspects of Anxiety
327   $a12. Brain Imaging and Anxiety Disorders13. Genetic Dissection of Anxiety and Related Disorders; 14. Respiration and Anxiety; 15. Pharmacological Challenge Agents In Anxiety; 16. Panic Disorder and Medical Illness; PART FOUR: Treatments; 17. Benzodiazepines; 18. Selective Serotonin Reuptake Inhibitors in the Treatment of the Anxiety Disorders; 19. Treatment of Anxiety Disorders with Tricyclic Antidepressants; 20. Buspirone in the Treatment of Anxiety Disorders; 21. Antihistamines in the Treatment of Psychic and Somatic Anxiety States; 22. Anxiety Disorders: New Antidepressants
327   $a23. Cognitive Behavioral Treatment of Anxiety Disorders24. Exposure Therapy in the Treatment of Anxiety Disorders; 25. Anxiety Disorders: Alternative Drug Treatments; 26. Physical Treatments; 27. Herbal Therapy and Anxiety; PART FIVE: CONCLUSION; 28. Anxiety Disorders: Current Needs and Future Prospects; Index
330   $aRapid developments in recent years in basic science and pharmacology has greatly increased understanding of the causes of anxiety disorders. This has led to a large number of new drug treatments from the pharmaceutical industry. This book makes sense of these advances and presents a coherent account of diagnosis and management from the clinical point of view. Chapters are in the form of surveys and digests of the recent literature and are interspersed with clinical guidelines, diagnostic and therapeutic points and are well illustrated.
606   $aAnxiety
615  0$aAnxiety.
676   $a616.85/223061
676   $a616.85223
701   $aNutt$b David J.$f1951-$0971935
701   $aBallenger$b James C$0983443
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910830050703321
996   $aAnxiety disorders$92245010
997   $aUNINA